{{Rsnum
|rsid=3745571
|Gene=DENND1C
|Chromosome=19
|position=6475602
|Orientation=minus
|GMAF=0.4881
|Gene_s=DENND1C
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 10.6 | 43.4 | 46.0
| HCB | 40.1 | 45.3 | 14.6
| JPT | 50.4 | 44.2 | 5.3
| YRI | 40.1 | 46.9 | 12.9
| ASW | 22.8 | 40.4 | 36.8
| CHB | 40.1 | 45.3 | 14.6
| CHD | 38.5 | 45.9 | 15.6
| GIH | 18.8 | 52.5 | 28.7
| LWK | 37.3 | 46.4 | 16.4
| MEX | 24.6 | 50.9 | 24.6
| MKK | 35.9 | 47.4 | 16.7
| TSI | 27.5 | 37.3 | 35.3
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (cyclophosphamide)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=T
  |Pval=8E-6
  |OR=1.73
  |ORtxt=[1.276-2.345]
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}